114 - EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN¿S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- ENDURE MAINTENANCE STUDY Julián Panés; Edward V. Loftus; Ana Lacerda; Laurent Peyrin- Biroulet; Geert D¿Haens; Remo Panaccione; Walter Reinisch; Edouard Louis; Minhu Chen; Hiroshi Nakase; Jakob Begun; Brigid S. Boland; Jianzhong Liu; Elena Dubcenco; Mohamed-Eslam F. Mohamed; Tian Feng; Jean-Frederic Colombel;

120 - CLINICAL AND ENDOSCOPIC IMPROVEMENTS WITH RISANKIZUMAB INDUCTION AND MAINTENANCE DOSING VERSUS PLACEBO ARE OBSERVED IRRESPECTIVE OF NUMBER OF PRIOR FAILED BIOLOGICS Marc Ferrante; Laurent Peyrin-Biroulet; Axel Dignass; David T. Rubin; Silvio Danese; Geert D¿Haens; Kristina Kligys; Sofie Berg; Jasmina Kalabic; Javier Zambrano; Yafei Zhang; Toshimitsu Fujii; Remo Panaccione; Ana Echarri Piudo;

118 - EFFICACY OF UPADACITINIB DOSE ESCALATION IN A PHASE 3 LONG-TERM EXTENSION ULCERATIVE COLITIS STUDY Remo Panaccione; Millie Long; Raja Atreya; Hiroshi Nakase; Wen Zhou; Xuan Yao; Dapo Ilo; Geert D¿Haens; Maria Dolores Martín Arranz;